Finance News Follow us to find the latest Finance news
MONTREAL – Valeant Pharmaceuticals International Inc.’s long fall is warming up the controversy over whether the company is having its own reporting metrics to sugarcoat a bitter financial situation, leading a former board person in the drugmaker’s predecessor Biovail to speak out against a trend that’s been adopted by some of Canada’s largest businesses. “It may not be illegal, but it is misleading,” said Spencer Lanthier, a ...
Read More »Valeant Pharmaceuticals’ use of non-GAAP financial reporting highlights widespread problems, former Biovail board member says
